Imaging risk in pulmonary arterial hypertension
- PMID: 32973075
- DOI: 10.1183/13993003.02313-2020
Imaging risk in pulmonary arterial hypertension
Conflict of interest statement
Conflict of interest: R. Badagliacca has received fees as speaker and scientific consultant for GSK, UT, Dompè, Ferrer, Bayer, MSD and AOPOrphan Pharmaceuticals. Conflict of interest: C.D. Vizza has received fees as speaker and scientific consultant for GSK, UT, Dompè, Bayer and MSD.
Comment on
-
A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension.Eur Respir J. 2020 Sep 24;56(3):2000513. doi: 10.1183/13993003.00513-2020. Print 2020 Sep. Eur Respir J. 2020. PMID: 32430422
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources